Taking Mounjaro Reduces Risk of Developing Diabetes by 94 Percent in Three-Year Trial

Quick Summary:

Preliminary results from a long-term study into the effects of Eli Lilly's weight loss injectable Zepbound suggest that it's extremely effective at reducing the risk of developing diabetes.

Lilly also added that anyone on oral birth control pills should also discuss changing medications because it's been shown to decrease their efficacy — a little-known side-effect that could be linked to the surprising number of unplanned pregnancies occurring when taking these new drugs.

As CNBC notes, this trial is the longest to date testing the effects of this new class of weight loss drugs.

---

More Pictures

---

Read Quick SummarySave Time

or

Article Details

Author / Journalist: Noor Al-Sibai

Category: Technology

Markets: United States

Topics: Eli lilly Rx/Medicines Neoscope Tirzepatide Mounjaro Diabetes

Source Website Secure: Yes (HTTPS)

News Sentiment: Neutral

Fact Checked: Legitimate

Article Type: News Report

Published On: 2024-08-21 @ 21:06:30 (12 hours ago)

News Timezone: GMT +8:00

News Source URL: futurism.com

Language: English

Article Length: 553 words

Reading Time: 4 minutes read

Sentences: 20 lines

Sentence Length: 28 words per sentence (average)

Platforms: Desktop Web, Mobile Web, iOS App, Android App

Copyright Owner: © Futurism

News ID: 22198966

View Article Analysis

About Futurism

Main Topics: Technology

Official Website: futurism.com

Update Frequency: 10 posts per day

Year Established: 1997

Headquarters: United States

News Last Updated: 11 hours ago

Coverage Areas: United States

Ownership: Independent Company

Publication Timezone: GMT +8:00

Content Availability: Worldwide

News Language: English

RSS Feed: Available (XML)

API Access: Available (JSON, REST)

Website Security: Secure (HTTPS)

Publisher ID: #68

Publisher Details

Frequently Asked Questions